Preliminary results from a phase 1/2, open-label, dose-escalation clinical trial of IMO-8400 in patients with relapsed or refractory Waldenstrom's macroglobulinemia Meeting Abstract
| Authors: | Thomas, S. K.; Harb, W. A.; Beck, J. T.; Nashat, G.; Palomba, M. L.; Ansell, S. M.; Eradat, H.; Libby, E. N.; Advani, R. H.; Hajdenberg, J.; Heffner, L. T.; Hoffman, J.; Vesole, D. H.; Simov, L.; Wyant, N.; Brevard, J.; O'Leary, J.; Agrawal, S. |
| Abstract Title: | Preliminary results from a phase 1/2, open-label, dose-escalation clinical trial of IMO-8400 in patients with relapsed or refractory Waldenstrom's macroglobulinemia |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019005018 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.1540.1540 |
| Notes: | Meeting Abstract: 1540 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
